These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30938376)

  • 21. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
    Ilyina NI; Edin AS; Astafieva NG; Lopatin AS; Sidorenko IV; Ukhanova OP; Khanova FM
    Int Arch Allergy Immunol; 2019; 178(3):255-263. PubMed ID: 30677766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis.
    van Weissenbruch R; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; Kuhl HC; Pohl W; Scadding GK; Price D; Mullol J
    J Asthma Allergy; 2020; 13():633-645. PubMed ID: 33293835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal spray medications for maintenance therapy of allergic rhinitis.
    Berger WE; Meltzer EO
    Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Comparison of Health Care Resource Utilization and Costs for Patients with Allergic Rhinitis on Single-Product or Free-Combination Therapy of Intranasal Steroids and Intranasal Antihistamines.
    Harrow B; Sedaghat AR; Caldwell-Tarr A; Dufour R
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1426-1436. PubMed ID: 27882840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhinology future trends: 2017 EUFOREA debate on allergic rhinitis.
    Scadding G; Bousquet J; Bachert C; Fokkens WJ; Hellings PW; Prokopakis E; Pfaar O; Price D
    Rhinology; 2019 Feb; 57(1):49-56. PubMed ID: 30052697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.
    Zhou B; Cheng L; Pan J; Wang H; Jin Y; Zhao C; Lin P; Tan G; Fang H; Zhang H; Zhou H; Dong Y; Kuhl HC; Ramalingam RK; Nguyen DT
    Pulm Ther; 2023 Sep; 9(3):411-427. PubMed ID: 37580498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Use of Azelastine Hydrochloride/Fluticasone Propionate in the Management of Allergic Rhinitis in Asia: A Review.
    Tantilipikorn P; Kirtsreesakul V; Bunnag C; Vangveeravong M; Thanaviratananich S; Chusakul S
    J Asthma Allergy; 2024; 17():667-679. PubMed ID: 39045291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis.
    Klimek L; Mullol J; Hellings P; Gevaert P; Mösges R; Fokkens W
    Expert Opin Pharmacother; 2016; 17(5):657-69. PubMed ID: 26800187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care.
    De Jong HJI; Voorham J; Scadding GK; Bachert C; Canonica GW; Smith P; Wahn U; Ryan D; Castillo JA; Carter VA; Murray RB; Price DB
    World Allergy Organ J; 2020 Dec; 13(12):100490. PubMed ID: 33376573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management.
    Bachert C; Bousquet J; Hellings P
    Clin Transl Allergy; 2018; 8():25. PubMed ID: 29983907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US.
    Prenner BM
    J Asthma Allergy; 2016; 9():135-43. PubMed ID: 27468241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers.
    Roca-Ferrer J; Pujols L; Pérez-González M; Alobid I; Callejas B; Vicens-Artés S; Fuentes M; Valero A; Picado C; Castor D; Nguyen D; Mullol J
    Allergy Asthma Clin Immunol; 2018; 14():86. PubMed ID: 30574167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of in vitro Penetration of Fluticasone Propionate from MP-AzeFlu and Fluticasone Propionate Nasal Spray Through EpiAirway™606 Tissues Using Vertical Diffusion Cells.
    Berger WE; Bachert C; Allara R; Koltun A; Kopietz F; Maus JG; D'Addio AD
    J Asthma Allergy; 2020; 13():187-192. PubMed ID: 32547111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergic rhinitis - effective treatment according to the latest recommendations.
    Arcimowicz M
    Otolaryngol Pol; 2022 Dec; 76(6):45-59. PubMed ID: 36805979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of uncontrolled allergic rhinitis in Wuhan, China: a prospective cohort study.
    Wang Y; Zhu R; Liu G; Li W; Chen H; Daurès JP; Chiriac AM; Demoly P
    Am J Rhinol Allergy; 2014; 28(5):397-403. PubMed ID: 25198026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option.
    Bjermer L; Westman M; Holmström M; Wickman MC
    Allergy Asthma Clin Immunol; 2019; 15():24. PubMed ID: 31015846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Over diagnosis of persistent allergic rhinitis in perennial allergic rhinitis patients: a nationwide study in Mexico.
    Larenas-Linnemann D; Dinger H; Shah-Hosseini K; Michels A; Mösges R;
    Am J Rhinol Allergy; 2013; 27(6):495-501. PubMed ID: 24274225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients - The ADRIAL cohort study.
    del Cuvillo A; Montoro J; Bartra J; Valero A; Ferrer M; Jauregui I; Dávila I; Sastre J; Mullol J
    Rhinology; 2010 Jun; 48(2):201-5. PubMed ID: 20502761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of MP-AzeFlu compared to monotherapy on COX-2, PGE
    Vicens-Artes S; Roca-Ferrer J; Tubita V; Fuentes M; Alobid I; Valero A; Kopietz F; Nguyen D; Mullol J
    Immun Inflamm Dis; 2023 Jan; 11(1):e709. PubMed ID: 36705401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergic Rhinitis Control Test questionnaire-driven stepwise strategy to improve allergic rhinitis control: a prospective study.
    Wang Y; Chen H; Zhu R; Liu G; Huang N; Li W; Yang L; Zhang S; Qi S; Daurès JP; Chiriac AM; Demoly P
    Allergy; 2016 Nov; 71(11):1612-1619. PubMed ID: 27332957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.